Advisory Services Network’s Sonnet BioTherapeutics SONN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-406
| Closed | -$35K | – | 1538 |
|
2023
Q2 | $35K | Buy |
406
+341
| +525% | +$29.4K | ﹤0.01% | 1416 |
|
2023
Q1 | $4.12K | Buy |
65
+12
| +23% | +$760 | ﹤0.01% | 3211 |
|
2022
Q4 | $10.7K | Buy |
+53
| New | +$10.7K | ﹤0.01% | 2828 |
|
2022
Q3 | – | Sell |
-53
| Closed | -$37K | – | 1440 |
|
2022
Q2 | $37K | Buy |
53
+32
| +152% | +$22.3K | ﹤0.01% | 1346 |
|
2022
Q1 | $19K | Hold |
21
| – | – | ﹤0.01% | 1435 |
|
2021
Q4 | $21K | Buy |
21
+8
| +62% | +$8K | ﹤0.01% | 1390 |
|
2021
Q3 | $20K | Sell |
13
-1
| -7% | -$1.54K | ﹤0.01% | 1373 |
|
2021
Q2 | $53K | Buy |
14
+3
| +27% | +$11.4K | ﹤0.01% | 1970 |
|
2021
Q1 | $61K | Buy |
11
+1
| +10% | +$5.55K | ﹤0.01% | 1260 |
|
2020
Q4 | $55K | Buy |
10
+2
| +25% | +$11K | ﹤0.01% | 1616 |
|
2020
Q3 | $48K | Buy |
+8
| New | +$48K | ﹤0.01% | 1615 |
|